Cargando…
Tay-Sachs Carrier Screening by Enzyme and Molecular Analyses in the New York City Minority Population
Background and Aims: Carrier screening for Tay-Sachs disease is performed by sequence analysis of the HEXA gene and/or hexosaminidase A enzymatic activity testing. Enzymatic analysis (EA) has been suggested as the optimal carrier screening method, especially in non-Ashkenazi Jewish (non-AJ) individu...
Autores principales: | Mehta, Nikita, Lazarin, Gabriel A., Spiegel, Erica, Berentsen, Kathleen, Brennan, Kelly, Giordano, Jessica, Haque, Imran S., Wapner, Ronald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314723/ https://www.ncbi.nlm.nih.gov/pubmed/27362553 http://dx.doi.org/10.1089/gtmb.2015.0302 |
Ejemplares similares
-
Enfermedad de Tay Sachs
por: Cibrián Cruz, José Alberto
Publicado: (1996) -
Screening for Tay‐Sachs disease carriers by full‐exon sequencing with novel variant interpretation outperforms enzyme testing in a pan‐ethnic cohort
por: Cecchi, Alana C., et al.
Publicado: (2019) -
Therapeutic Strategies For Tay-Sachs Disease
por: Picache, Jaqueline A., et al.
Publicado: (2022) -
Comparison of enzyme and DNA analysis in a Tay-Sachs disease carrier screening program.
por: Yoo, H. W., et al.
Publicado: (1993) -
New Approaches to Tay-Sachs Disease Therapy
por: Solovyeva, Valeriya V., et al.
Publicado: (2018)